Hilar lymphadenopathy, development of tubulointerstitial nephritis, and dense deposit disease following Pfizer-BioNTech COVID-19 vaccination

Despite the reports on glomerulonephritis associated with COVID-19 mRNA vaccines, no study has reported about the dense deposit disease (DDD). Here, we present a case of hilar lymphadenopathy after the COVID-19 mRNA vaccination, following which the patient developed tubulointerstitial nephritis (TIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Hironori, Ueda, Michiko, Anayama, Mariko, Makino, Mutsuki, Makino, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747079/
https://www.ncbi.nlm.nih.gov/pubmed/36513952
http://dx.doi.org/10.1007/s13730-022-00762-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747079/
https://www.ncbi.nlm.nih.gov/pubmed/36513952
http://dx.doi.org/10.1007/s13730-022-00762-7

Ejemplares similares